Last $48.85 USD
Change Today -0.90 / -1.81%
Volume 298.7K
WBMD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

webmd health corp (WBMD) Key Developments

WebMD Health Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Provides Earnings Guidance for the Third Quarter and Full Year of 2014

WebMD Health Corp. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of $140,400,000 against $125,317,000 a year ago. Income before income tax provision was $17,087,000 against $4,214,000 a year ago. Net income was $9,716,000 or $0.23 per diluted share against $2,611,000 or $0.05 per diluted share a year ago. Earnings before interest, taxes, non-cash and other items was $37,917,000, compared to $29,241,000 in the prior year period, an increase of 30%. For the six months, the company reported revenue of $274,232,000 against $238,079,000 a year ago. Income before income tax provision was $28,178,000 against $2,902,000 a year ago. Net income was $15,982,000 or $0.38 per diluted share against $1,073,000 or $0.02 per diluted share a year ago. Net cash provided by operating activities was $41,978,000 against $33,994,000 a year ago. Purchases of property and equipment were $11,446,000 against $7,367,000 a year ago. Earnings before interest, taxes, non-cash and other items was $71,183,000 against $50,530,000 a year ago. For the third quarter of 2014, the company expects revenue to be approximately $140 million to $143 million, an increase of approximately 7% to 9% from the prior year period. Adjusted EBITDA to be approximately $37.5 million to $39.5 million, an increase of approximately 18% to 25% from the prior year period. Net income to be approximately $8.5 million to $9.5 million. For the year ending December 31, 2014, the company expects revenue to be approximately $570 million to $580 million, an increase of approximately 11% to 13% from the prior year period. Adjusted EBITDA to be approximately $152.5 million to $157.5 million, an increase of approximately 24% to 28% from the prior year period. Net income to be approximately $36.5 million or $0.87 per diluted share to $40.5 million or $0.92 per diluted share. Interest expense, net to be in the range of $25.0 million to $25.0 million. Pre-tax income to be in the range of $64.0 million to $71.0 million. Depreciation and amortization to be in the range of $30.0 million against $29.0 million a year ago.

WebMD Health Corp. to Report Q2, 2014 Results on Aug 05, 2014

WebMD Health Corp. announced that they will report Q2, 2014 results at 4:00 PM, US Eastern Standard Time on Aug 05, 2014

WebMD Health Corp., Q2 2014 Earnings Call, Aug 05, 2014

WebMD Health Corp., Q2 2014 Earnings Call, Aug 05, 2014

WebMD Health Corp. Appoints Kristiina Vuori to its Board

WebMD Health Corp. announced that its Board of Directors has appointed Kristiina Vuori, M.D., Ph.D., President and Interim CEO of Sanford-Burnham Medical Research Institute, to the company's Board. Dr. Vuori leads the Institute's academic, scientific and general operations. Dr. Vuori also holds the Pauline and Stanley Foster Presidential Chair at the Institute and serves as Professor at the Institute's National Cancer Institute (NCI)-designated Cancer Center. From 2005 until 2013, Dr. Vuori also led the Cancer Center. Dr. Vuori serves on the Boards of Directors for the American Association for Cancer Research (AACR), the California Institute for Regenerative Medicine (CIRM), and the California Breast Cancer Research Council. Additionally, Dr. Vuori serves in a wide variety of advisory capacities to NCI and other cancer organizations. Dr. Vuori is joining WebMD's Board as an additional Class III director. Class III directors' current terms expire at the company's 2014 annual meeting of stockholders. Her appointment expands the size of WebMD's Board from 10 to 11 members.

WebMD Launches Health Improvement Program for iPhone(R) to Make Biometric Data Understandable and Actionable

WebMD Health Corp. launched WebMD Healthy Target, an integrated health improvement program that uses biometric device data from activity trackers, wireless scales and glucose meters to deliver tailored, physician-reviewed, contextually relevant content and motivational tips to individuals looking to develop sustainable health-conscious habits. WebMD Healthy Target will provide valuable assistance to individuals looking to manage chronic conditions like Type 2 diabetes and obesity, as well as to a broader audience interested in achieving their fitness goals or more generally living a healthier lifestyle.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WBMD:US $48.85 USD -0.90

WBMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WBMD.
View Industry Companies
 

Industry Analysis

WBMD

Industry Average

Valuation WBMD Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEBMD HEALTH CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.